Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Anti-idiotypic
Patent
1993-10-12
1996-10-01
Feisee, Lila
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Anti-idiotypic
4241401, 5303872, A61K 39395, C07K 1618, C07K 1642
Patent
active
055609112
ABSTRACT:
Antibodies directed against idiotypes on naturally occurring human anti-animal antibodies are disclosed for use in inhibiting xenograft rejection in human patients. An effective quantity of these anti-idiotypic antibodies is injected into the actual or potential xenograft recipient in order to bind to the idiotypes expressed on anti-animal antibodies as well as subpopulations of B lymphocytes, to inhibit hyperacute rejection of transplanted animal tissues or organs by the human patient. Alternatively, anti-idiotypic antibodies are used in the form of immunoaffinity columns to deplete anti-animal antibodies from the recipient's serum. Methods of making mouse monoclonal, mouse recombinant, and human recombinant anti-idiotypic antibodies are described, as well as immunoaffinity columns containing immobilized anti-idiotypic antibodies. A method and means for assessing the expected character and severity of a patient's rejection response to transplanted animal tissues is described, as well as methods of identification, isolation and suppression of lymphocytes bearing anti-animal idiotypes.
REFERENCES:
patent: 5215904 (1993-06-01), Gould et al.
Fischel, R. J. et al., Transplantation Proceedings, 22(3): 1077-1078, 1990.
Sandrin, M. S. et al., PNAS, 90:11391-11395, Dec. 1993.
Cooper, D. K. C. "Is Xenotransplantation a Realistic Clinical Option?" Trans Proc, 24(5):2393-2396 (1992).
Salam e, et al., "Rejet hyperaigu x enog eigue; tentative de traitement a l'aide d'anticorps anti-idiotypigues," La Presse M edicale 21, n.degree. 41:1945-1946 (1992) (Abstract Only).
Abdou, N. I., et al., "In Virro Suppression of Serum Anti-DNA Antibody Binding to DNA by Anti-Idiotypic Antibody in Systemic Lupus Erythematosus", J. Clin. Invest., 67:1297-1304 (May, 1981).
Bach, F. H., et al., "Accomodation: A Working Paradigm for Progressing Toward Clinical Discordant Xenograting", Transplant. Proc., 23(1):205-207 (Feb., 1991).
Brodsky, F. M., et al., "Evolution of HLA Antigenic Determinants; Species Cross-reactions of Monoclonal Antibodies", Immunogenetics, 155:151-166 (1982).
Clackson, T., et al., "Making Antibody Fragments Using Phage Display Libraries", Nature, 352:624-888 (Aug., 1991).
Cooper, D. K. C., et al., "The Pig as Potential Organ Doner for Man", Xenotransplantation, Springer-Verlag:481-500 (1991).
Cooper, D. K. C., et al., "Effects of Cyclosporine and Antibody Adsorption on Pig Cardiac Xenograft Survival in the Baboon", J. Heart Transplant, 7:238-246 (May/Jun., 1988).
Cooper, D. K. C., "Immediat Postoperative Care and Maintenance Immunosuppressive Therapy", 89-100 in Cooper, D. K. C. and Novitsky, D., eds., The Transplantation and Replacement of Thoracic Organs, (Kluwer, Dordrecht 1990).
Daugherty, B. L., et al., "Polymerase Chain Reaction Facilitates the Cloning, CDR-Grafting, and Rapid Expression of a Murine Monoclonal Antibody Directed Against the CD18 Component of Leukecyte Integrins", Nucl. Acids Res. 19:2471-2476 (1981).
Galili, U., et al., "A Unique Natural Human IgG Antibody with Anti-.alpha.-Galactosyl Specificity", J. Exp. Med., 160:1519-1531 (Nov., 1984).
Galili, U., et al., "Interaction Between Human Natural Anti-.alpha.-Galactosyl Immunoblobulin G. and Bacteria of the Human Flora", Infection and Immunity, 56(7):1730-1737 (Jul. 1988).
Garver, J. J., et al., "Evidence of Similar Organization of the Chromosomes Carrying the Major Histocompatibility Complex in Man and Other Primates ", Cytogenetics & Cell Genetics, 27:238-245 (1980).
Geller, R. L., et al., "Evidence that Polyreactaive Antibodies are Deposited in Rejected Discordant Xenografts", Transplantation 55:168-172 (Jan., 1993).
Good, A. H., et al., "Identification of Carbohydrate Structures that Bind Human Antiporcine Antibodies: Implications for Discordant Xenografting in Humans", Transplant Proc., 24(2):559-652 (Apr. 1992).
Hammer, C., "Evolutionary Considerations in Xenotransplantation", Xenograft, 25:115-123 (1989).
Hammer, C., et al., "Evolutionary, Physiological, and Immunological Considerations in Defining a Suitable Donor for Man", Xenotransplantation, 429-438 (1991).
Jerne, N. K., et al., "Recurrent Idiotopes and Internal Images", EMBO Journal, 1:243-247 (Feb., 1982).
Koren, E., et al., "Heterogeneity of Preformed Human Antipig Xenogenic Antibodies", Transplant Proc., 24(2):598-601 (Apr., 1992).
Lexer, G., et al., "Hyperacute Rejection in a Discondant (Pig to Baboon) Cardiac Xenograft Model", J. Heart Transplant, 4:411-418 (1986).
McCafferty, J., et al., "Phage Antibodies: Filamentous Phage Displaying Antibody Variable Domains", Nature, 348:552-554 (Dec., 1990).
Meeker, T. C. J., et al., "A Clinical Trial of Anti-Idiotype Therapy for B Cell Malignancy", Blood, 65:1349-1355 (Jun. 1985).
Michler, R. E., et al., "Prolongation of Primate Cardiac Xenograft Survival with Cyclosporine", Transplantation, 44(5)632-636 (Nov., 1987).
Miyajima, T., et al., "Anti-Idiotypic Antibodies in a Patient with a Functioning Renal Graft", Nature, 283:306-308 (Jan., 1980).
Neubauer, R. H., et al., "Reactaivity of Monochonal Antibodies Against Human Leucocyte Antigens with Lymphocytes of Non-Human Primate Origin", J. Immunogenatics, 8:433-442 (Dec., 1981).
Norman, D. J., et al., "Consenus Statement Regarding OKT3-Induced Cytokine-Release Syndrome and Human Antimouse Antibodies", Transplant Proc., 25(2):1:89-92 (Apr., 1983).
Oosterlaken, T. A. M., et al., "A Neutralization-Inhibition Enzyme Immunoassay for Anti-Idiotypic Antibodies that Block Monoclonal Antibodies Neutralizing Semliki Forest Virus", J. Immunol, Methods, 115:255-261 (1988).
Paul, L. C., et al., "Mechanism of Humoral Xenograft Rejection", Xenotransplantation, 47-67 (1991).
Platt, J. L., et al., "Mechanism of Tissue Injury in Hyperacute Xenograft Rejection", Xenotransplantation, 69-79 (Aug., 1991).
Platt, J. L., et al., "Immunopathology of Hypercute Xenograft Rejection in a Swine-to-Primate Model", Transplantation, 52(2):214-220 (1991).
Polanka, E., et al., "Anti-Idiotypic Antibodies to HLA After Donor-Specific Blood Transfusion (DST)", Transplant, Proc., 21:1806-1809 (Feb., 1989).
Reed, E., et al., "Effect of Antidiotypic Antibodies to HLA on Graft Survival in Renal-Allograft Recipients", New Engl. J. Med., 316:1450-1455 (Jun., 1987).
Reed, E., et al., "Effect of Anti-HLA and Anti-Idiotypic Antibodies on the Long-Term Survival of Heart and Kidney Allografts", Transplant, Proc., 24:2494-2495 (Dec., 1992).
Rodey, J. E., et al., "Association of Antiidiotypic Antibody with Successful Second Transplant of a Kidney Sharing HLA Antigens with the Previous Hyperacutely Rejected First Kidney", Transplantation, 48-54-57 (Jul., 1989).
Sasaki, T., et al., "Selective Elimination of Anti-DNA Antibody-producing Cells by Antiidiotypic Antibody Conjugated with Neocarzinostatin", J. Clin. Invest., 77:1382-1386 (1986).
Simpson, M. A., et al., "Immunosuppression in Xenotransplantation", Xenograft, 25:273-284 (1989).
Somerville, C. A., et al., "Future Directions in Transplantion: Xenotransplantation", Kidney Int., 44942):S112-S121 (193).
Stark, J. H., et al., "Immunological Compatibility Between the Chacma Baboon and Man", Transplantation, 52(6):1072-1078 (Dec., 1991).
Tsuijsaki, M., et al., "A Sandwich Assay to Detect and Characterize Syngeneic Anti-Idiotypic Antibodies to murine Anti-HLA and Tumor Associated Associated Antigen Monochonal Antibodies", J. Immunol. Methods, 95:47-55 (1986).
Welsh, K. L., et al., "Human Antibodies to Pig Determinants and Their Association with Hyperacute Rejection of Xenografts", Xenotransplantation, 501-510 (1991).
Werner, R. G., et al., "Safety and Economic Aspects of Continuous Mammalian Cell Culture", J. Biotechnol., 22:51-68 (1992).
Ye, Y., Cooper, et al., "Experimental Xenotransplantation in Nonhuman Primates Using Distantly Related Donor Species", Xenotransplantation, 389-393 (1991).
Cooper David K. C.
Koren Eugen
Feisee Lila
Integris Baptist Medical Center, Inc.
Loring Susan A.
Oklahoma Medical Research Foundation
LandOfFree
Method of inhibiting acute complement mediated cytotoxicity with does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting acute complement mediated cytotoxicity with, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting acute complement mediated cytotoxicity with will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1500561